 |
|
| BIOLOGICS AND THERAPEUTICS OF IBD, AN ISSUE OF GASTROENTEROLOGY CLINICS, 35-4
| |
| | |
|
|
To order this title, and for more information, click here
By
Gary Lichtenstein, MD, Department of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA
Included in series
The Clinics: Internal Medicine,
Description
Dr. Gary Lichtenstein, one of the top experts on IBD, has assimilated an international group of experts who will explore the use of infliximab
and other similar biologics for use in patients with Ulcerative Colitis, luminal Crohn's Disease and fistulizing Crohn's disease. The
perceived mechanisms of action, and adverse events will be reviewed. Similar agents under investigation will be reviewed. The review
will focus on clinically relevant issues for the practicing clinician and also focus on important laboratory based information that the
investigator needs to know. Areas of focus include regulatory issues with biologics in IBD, management of infusion reactions in patients
receiving infliximab, the economics of use of biologics, recognizing and preventing adverse events with use of infliximab and other biologics,
A review of putative targets for novel biologics and also a review of current agents under investigation will also be included. This
guide for the experienced researcher and for the novice who has yet to use biologic therapy to treat IBD will be a state of the art overview
of the current literature for infliximab and other biologics in IBD. Gastroenterologists, surgeons, family physicians, gynecologists,
internists, medical students, nurses and all other health care deliverers who are caring for patients with Inflammatory bowel disease
must have this issue because it focuses is on clinically relevant topics, patient management issues; laboratory-based investigations
will be touched upon with a translational focus. Key Words: Biologics, Infliximab, monoclonal antibody, Crohn's Disease, Fistulae, Ulcerative
Colitis, Refractory Crohn's Disease, novel therapy, economics, fistulae, luminal Crohn's disease, infusion reactions.
| Bibliographic details |
Hardbound, 240 pages, publication date: DEC-2006
ISBN-13: 978-1-4160-3555-8
ISBN-10: 1-4160-3555-9
Imprint: SAUNDERS
|
041/407
Last update: 13 Jun 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Websites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company